Scilex Holding (SCLX) Beginning Cash Balance (2021)

Scilex Holding (SCLX) posted quarterly Beginning Cash Balance of -$55000.0 for Q3 2021, down 200.0% on a QoQ basis from $55000.0 in Q2 2021.

Scilex Holding (SCLX) Beginning Cash Balance (2021) Analysis & Trends

Scilex Holding (SCLX) has reported Beginning Cash Balance for 1 consecutive years, with -$55000.0 the latest figure, recorded in Q3 2021.

In Q3 2021, Beginning Cash Balance changed N/A year-over-year to -$55000.0; the TTM figure through Dec 2021 stood at $55000.0 (changed N/A YoY), while the FY2021 annual figure was $55000.0, changed N/A from the prior year.
Beginning Cash Balance came in at -$55000.0 for Q3 2021 at Scilex Holding, down from $55000.0 in the prior quarter.
The five-year high for Beginning Cash Balance was $55000.0 in Q1 2021, with the low at -$55000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Scilex Holding	54.30 Mn	-95.62 Mn	4.15 Mn

Download Data